Archives of Cardiovascular Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Paramedics and remote monitoring of cardiac implantable electronic devices in France
Arch Cardiovasc Dis. 2023 Nov 11:S1875-2136(23)00491-6. doi: 10.1016/j.acvd.2023.10.296. Online ahead of print.NO ABSTRACTPMID:38087663 | DOI:10.1016/j.acvd.2023.10.296 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Carole Mette Diane Prost Julien Baud Jerome Taieb Eloi Marijon Olivier Piot Source Type: research

Management of venous thromboembolic disease in patients with malignant brain tumours
This article addresses the management of venous thromboembolism in patients with malignant brain tumours, including both primary and secondary (metastatic) tumours. The available data on patients on venous thromboembolism recurrence and bleeding risks in patients with brain tumours is limited, since these patients have been excluded from most randomised, interventional, head-to-head, clinical trials comparing low molecular weight heparins to vitamin K antagonists or to direct oral Factor Xa inhibitors. More information is available from retrospective observational studies, which however were generally small, and carried a ...
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Isabelle Mah é Corinne Fr ère Gilles Pernod Olivier Sanchez Ahmed Id Baih INNOVTE CAT Working Group Source Type: research

Remote management in patients with heart failure (from new onset to advanced): A practical guide
Arch Cardiovasc Dis. 2023 Nov 30:S1875-2136(23)00523-5. doi: 10.1016/j.acvd.2023.11.013. Online ahead of print.ABSTRACTHeart failure is a chronic condition that affects millions of people worldwide and is associated with high morbidity and mortality. Remote monitoring, which includes the use of non-invasive connected devices, cardiac implantable electronic devices and haemodynamic monitoring systems, has the potential to improve outcomes for patients with heart failure. Despite the conceptual and clinical advantages, there are still limitations in the widespread use of these technologies. Moreover, a significant proportion...
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: C édric Klein Serge Boveda Pascal De Groote Michel Galinier Patrick Jourdain Jacques Mansourati Atul Pathak Fran çois Roubille R émi Sabatier Laurence Guedon-Moreau Source Type: research

Home treatment for patients with cancer-associated venous thromboembolism
Arch Cardiovasc Dis. 2023 Nov 23:S1875-2136(23)00521-1. doi: 10.1016/j.acvd.2023.11.012. Online ahead of print.ABSTRACTPatients hospitalised with acute venous thromboembolism (VTE), and notably patients with pulmonary embolism, often remain in hospital for extended periods due to the perceived risk of complications. However, several studies have shown that home treatment of selected patients is feasible and safe, with a low incidence of adverse events. This may offer clear benefits for patients' quality of life, hospital planning and cost to the health service. Nonetheless, there is a need for a VTE risk-stratification too...
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Olivier Sanchez Pierre-Marie Roy Yoann Gaboreau Jeannot Schmidt Far ès Moustafa Asmahane Benmaziane Antoine Elias Olivier Espitia Marie-Antoinette Sevestre Francis Couturaud Isabelle Mah é INNOVTE CAT Working Group Source Type: research

Anticoagulant treatment of cancer-associated thromboembolism
Arch Cardiovasc Dis. 2023 Nov 23:S1875-2136(23)00519-3. doi: 10.1016/j.acvd.2023.11.010. Online ahead of print.ABSTRACTVenous thromboembolism (VTE) is a frequent and potentially fatal complication in patients with cancer. During the initial period after the thromboembolic event, a patient receiving anticoagulant treatment is exposed both to a risk of VTE recurrence and also to an elevated bleeding risk conferred by the treatment. For this reason, the choice of anticoagulant is critical. The choice should take into account patient-related factors (such as functional status, age, body mass index, platelet count and renal fun...
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Isabelle Mah é Didier Mayeur Francis Couturaud Florian Scott é Ygal Benhamou Asmahane Benmaziane Laurent Bertoletti Silvy Laporte Philippe Girard Patrick Mismetti Olivier Sanchez INNOVTE CAT Working Group Source Type: research

Management of cancer-associated thromboembolism: Introduction
Arch Cardiovasc Dis. 2023 Nov 21:S1875-2136(23)00509-0. doi: 10.1016/j.acvd.2023.11.002. Online ahead of print.NO ABSTRACTPMID:38087662 | DOI:10.1016/j.acvd.2023.11.002 (Source: Archives of Cardiovascular Diseases)
Source: Archives of Cardiovascular Diseases - December 13, 2023 Category: Cardiology Authors: Isabelle Mah é Olivier Sanchez Patrick Mismetti Source Type: research